Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.
暂无分享,去创建一个
S. Shariat | G. Kramer | A. Haitel | M. Hassler | M. Abufaraj | A. Bruchbacher | N. Garstka | J. Stangl-Kremser | U. Lemberger | D. Ilijazi
[1] L. Cannon-Albright,et al. Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer , 2017, JAMA oncology.
[2] D. Tindall,et al. HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study. , 2016, The Lancet. Oncology.
[3] David F Jarrard,et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer. , 2015, The New England journal of medicine.
[4] K. Nastiuk,et al. Variant allele of HSD3B1 increases progression to castration‐resistant prostate cancer , 2015, The Prostate.
[5] Yongwei Yu,et al. miR‐663 Induces Castration‐Resistant Prostate Cancer Transformation and Predicts Clinical Recurrence , 2014, Journal of cellular physiology.
[6] P. Nelson,et al. A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer , 2013, Cell.
[7] Rui Li,et al. Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer , 2011, Proceedings of the National Academy of Sciences.
[8] R. Auchus,et al. 3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer. , 2010, Endocrinology.
[9] K. Knudsen,et al. Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer , 2010, Trends in Endocrinology & Metabolism.
[10] S. Shariat,et al. Perspectives on prostate cancer biomarkers. , 2008, European urology.
[11] J. Carpten,et al. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility. , 2002, Cancer research.
[12] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. , 2002, The Journal of urology.
[13] J. Varley,et al. Cloning, expression, and physical mapping of the 3beta-hydroxysteroid dehydrogenase gene cluster (HSD3BP1-HSD3BP5) in human. , 1999, Genomics.
[14] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[15] S. Balk,et al. Mechanisms mediating androgen receptor reactivation after castration. , 2009, Urologic oncology.